FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993245114> ?p ?o ?g. }

• W1993245114 endingPage "545" @default.
• W1993245114 startingPage "537" @default.
• W1993245114 abstract "PARP inhibitors, both as monotherapy and in combination with cytotoxic drugs, are currently undergoing clinical trials in several different cancer types. In this investigation, we compared the antiproliferative activity of two PARP/putative PARP inhibitors, i.e., olaparib and iniparib, in a panel of 14 breast cancer cell lines (seven tripe-negative and seven non-triple-negative). In almost all cell lines investigated, olaparib was a more potent inhibitor of cell growth than iniparib. Inhibition by both drugs was cell line-dependent and independent of the molecular subtype status of the cells, i.e., whether cells were triple-negative or non-triple negative. Although the primary target of PARP inhibitors is PARP1, no significant association was found between baseline levels of PARP1 activity and inhibition with either agent. Similarly, no significant correlation was evident between sensitivity and levels of CDK1, BRCA1 or miR-182. Combined addition of olaparib and either the CDK1 inhibitor, RO-3306 or a pan HER inhibitor (neratinib, afatinib) resulted in superior growth inhibition to that obtained with olaparib alone. We conclude that olaparib, in contrast to iniparib, is a strong inhibitor of breast cancer cell growth and may have efficacy in breast cancer irrespective of its molecular subtype, i.e., whether HER2-positive, estrogen receptor (ER)-positive or triple-negative. Olaparib, in combination with a selective CDK1 inhibitor or a pan HER inhibitor, is a potential new approach for treating breast cancer." @default.
• W1993245114 created "2016-06-24" @default.
• W1993245114 creator A5021160836 @default.
• W1993245114 creator A5025907836 @default.
• W1993245114 creator A5032474505 @default.
• W1993245114 creator A5034725210 @default.
• W1993245114 creator A5042172750 @default.
• W1993245114 creator A5060216161 @default.
• W1993245114 creator A5067762018 @default.
• W1993245114 creator A5071658639 @default.
• W1993245114 creator A5072021902 @default.
• W1993245114 date "2013-06-10" @default.
• W1993245114 modified "2023-10-16" @default.
• W1993245114 title "Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines" @default.
• W1993245114 cites W1523531555 @default.
• W1993245114 cites W1980721628 @default.
• W1993245114 cites W1992397774 @default.
• W1993245114 cites W1993119044 @default.
• W1993245114 cites W1996931025 @default.
• W1993245114 cites W2022309076 @default.
• W1993245114 cites W2035064970 @default.
• W1993245114 cites W2061001563 @default.
• W1993245114 cites W2086038769 @default.
• W1993245114 cites W2090031006 @default.
• W1993245114 cites W2110017381 @default.
• W1993245114 cites W2110878808 @default.
• W1993245114 cites W2111429259 @default.
• W1993245114 cites W2113552475 @default.
• W1993245114 cites W2114416638 @default.
• W1993245114 cites W2116251667 @default.
• W1993245114 cites W2117964602 @default.
• W1993245114 cites W2118723994 @default.
• W1993245114 cites W2121415861 @default.
• W1993245114 cites W2130084494 @default.
• W1993245114 cites W2134539328 @default.
• W1993245114 cites W2144510519 @default.
• W1993245114 cites W2145011037 @default.
• W1993245114 cites W2149122422 @default.
• W1993245114 cites W2155244882 @default.
• W1993245114 cites W2170476788 @default.
• W1993245114 cites W2171972386 @default.
• W1993245114 cites W2589359420 @default.
• W1993245114 cites W3093265161 @default.
• W1993245114 doi "https://doi.org/10.4161/cbt.24349" @default.
• W1993245114 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3813570" @default.
• W1993245114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23760496" @default.
• W1993245114 hasPublicationYear "2013" @default.
• W1993245114 type Work @default.
• W1993245114 sameAs 1993245114 @default.
• W1993245114 citedByCount "34" @default.
• W1993245114 countsByYear W19932451142013 @default.
• W1993245114 countsByYear W19932451142014 @default.
• W1993245114 countsByYear W19932451142015 @default.
• W1993245114 countsByYear W19932451142016 @default.
• W1993245114 countsByYear W19932451142017 @default.
• W1993245114 countsByYear W19932451142018 @default.
• W1993245114 countsByYear W19932451142019 @default.
• W1993245114 countsByYear W19932451142020 @default.
• W1993245114 countsByYear W19932451142021 @default.
• W1993245114 countsByYear W19932451142023 @default.
• W1993245114 crossrefType "journal-article" @default.
• W1993245114 hasAuthorship W1993245114A5021160836 @default.
• W1993245114 hasAuthorship W1993245114A5025907836 @default.
• W1993245114 hasAuthorship W1993245114A5032474505 @default.
• W1993245114 hasAuthorship W1993245114A5034725210 @default.
• W1993245114 hasAuthorship W1993245114A5042172750 @default.
• W1993245114 hasAuthorship W1993245114A5060216161 @default.
• W1993245114 hasAuthorship W1993245114A5067762018 @default.
• W1993245114 hasAuthorship W1993245114A5071658639 @default.
• W1993245114 hasAuthorship W1993245114A5072021902 @default.
• W1993245114 hasBestOaLocation W19932451141 @default.
• W1993245114 hasConcept C104317684 @default.
• W1993245114 hasConcept C121608353 @default.
• W1993245114 hasConcept C126322002 @default.
• W1993245114 hasConcept C143998085 @default.
• W1993245114 hasConcept C182979987 @default.
• W1993245114 hasConcept C2775930923 @default.
• W1993245114 hasConcept C2776387010 @default.
• W1993245114 hasConcept C2779138821 @default.
• W1993245114 hasConcept C2779438470 @default.
• W1993245114 hasConcept C2779962180 @default.
• W1993245114 hasConcept C2780110267 @default.
• W1993245114 hasConcept C2780580887 @default.
• W1993245114 hasConcept C2780586478 @default.
• W1993245114 hasConcept C502942594 @default.
• W1993245114 hasConcept C530470458 @default.
• W1993245114 hasConcept C55493867 @default.
• W1993245114 hasConcept C71924100 @default.
• W1993245114 hasConcept C82381507 @default.
• W1993245114 hasConcept C86803240 @default.
• W1993245114 hasConceptScore W1993245114C104317684 @default.
• W1993245114 hasConceptScore W1993245114C121608353 @default.
• W1993245114 hasConceptScore W1993245114C126322002 @default.
• W1993245114 hasConceptScore W1993245114C143998085 @default.
• W1993245114 hasConceptScore W1993245114C182979987 @default.
• W1993245114 hasConceptScore W1993245114C2775930923 @default.
• W1993245114 hasConceptScore W1993245114C2776387010 @default.
• W1993245114 hasConceptScore W1993245114C2779138821 @default.

• next